Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia.
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: A high proportion of patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia die within a few days of the onset of infection. However, predictive factors for early mortality (EM) have barely been examined. The aim of this study was to determine the predictive factors for EM in patients with MRSA bacteraemia. METHODS: All episodes of MRSA bacteraemia were prospectively followed in 21 Spanish hospitals from June 2008 to December 2009. Epidemiology, clinical data, therapy and outcome were recorded. All MRSA strains were analysed in a central laboratory. Mortality was defined as death from any cause occurring in the 30 days after the onset of MRSA bacteraemia. EM was defined as patients who died within the first 2 days, and late mortality (LM) for patients who died after this period. Multivariate analyses were performed by using logistic regression models. RESULTS: A total of 579 episodes were recorded. Mortality was observed in 179 patients (31%): it was early in 49 (8.5%) patients and late in 130 (22.5%). Independent risk factors for EM were [OR (95% CI)] initial Pitt score >3 [3.99 (1.72-3.24)], previous rapid fatal disease [3.67 (1.32-10.24)], source of infection lower respiratory tract or unknown [3.76 (1.31-10.83) and 2.83 (1.11-7.21)], non-nosocomial acquisition [2.59 (1.16-5.77)] and inappropriate initial antibiotic therapy [3.59 (1.63-7.89)]. When predictive factors for EM and LM were compared, inappropriate initial antibiotic therapy was the only distinctive predictor of EM, while endocarditis and lower respiratory tract sources both predicted LM. CONCLUSIONS: In our large cohort of patients several factors were related to EM, but the only distinctive predictor of EM was inappropriate initial antibiotic therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among patients with documented MRSA infections, delays of > 24–48 h until antibiotic administration are associated with increased mortality in some studies [143–147], but not in others [148–154].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [143]
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., & Swaminathan, B. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.9.2233-2239.1995 · Cited by 8,204
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
CDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770
Enright, M. C., Day, N. P. J., Davies, C. E., Peacock, S. J., & Spratt, B. G. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.3.1008-1015.2000 · Cited by 3,063
Lina, G., Piemont, Y., Godail-Gamot, F., Bes, M., Peter, M.-O., Gauduchon, V., Vandenesch, F., & Etienne, J. (1999) · Clinical Infectious Diseases · doi:10.1086/313461 · Cited by 2,489
Cosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber, M. J., Karchmer, A. W., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/345476 · Cited by 1,964
Friedman, N. D., Kaye, K. S., Stout, J. E., McGarry, S. A., Trivette, S. L., Briggs, J. P., Lamm, W., Clark, C., MacFarquhar, J., Walton, A. L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-10-200211190-00007 · Cited by 1,668
Kreger, B. E., Craven, D. E., & McCabe, W. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90102-3 · Cited by 1,314
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Geisinger, E., & Isberg, R. R. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw402 · Cited by 197
“This study provides a potential connection between inappropriate empiric antibiotic treatment of nosocomial MRSA infections and worsened clinical outcomes [89].”
BackgroundHumphreys, H., Fitzpatick, F., & Harvey, B. J. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ576 · Cited by 156
Variations in Organism-Specific Severe Sepsis Mortality in the United States: 1999–2008*
Ani, C., Farshidpanah, S., Bellinghausen Stewart, A., & Nguyen, H. B. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000000555 · Cited by 84
Characteristics of Staphylococcus aureus Bacteraemia and Predictors of Early and Late Mortality
Bassetti, M., Peghin, M., Trecarichi, E. M., Carnelutti, A., Righi, E., Giacomo, P. D., Ansaldi, F., Trucchi, C., Alicino, C., Cauda, R., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170236 · Cited by 86
Li, Z., Zhuang, H., Wang, G., Wang, H., & Dong, Y. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-05763-y · Cited by 80
Müller, S., Wolf, A. J., Iliev, I. D., Berg, B. L., Underhill, D. M., & Liu, G. Y. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.10.011 · Cited by 72
“Studies confirmed that initial inappropriate antibiotic treatment is an independent predictive factor for mortality during MRSA bacteremia (Gasch et al., 2013).”
BackgroundGasch, O., Camoez, M., Dominguez, M. A., Padilla, B., Pintado, V., Almirante, B., Martin, C., Lopez-Medrano, F., de Gopegui, E. R., Blanco, J. R., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt396 · Cited by 71
Self-citationSong, K., Kim, H. B., Kim, H.-S., Lee, M. J., Jung, Y., Kim, G., Hwang, J.-H., Kim, N., Kim, M., Kim, C.-J., et al. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.09.010 · Cited by 62
Determinants of inappropriate empirical antibiotic treatment: systematic review and meta-analysis
Carrara, E., Pfeffer, I., Zusman, O., Leibovici, L., & Paul, M. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.12.013 · Cited by 67
The ZEPHyR study: A randomized comparison of linezolid and vancomycin for MRSA pneumonia
Chavanet, P. (2013) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2013.09.011 · Cited by 47
López-Cortés, L. E., Gálvez-Acebal, J., del Toro, M. D., Velasco, C., de Cueto, M., Caballero, F. J., Muniain, M. A., Pascual, Á., & Rodríguez‐Baño, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082958 · Cited by 39
“Sources of SAB associated with high mortality in previous studies were classified as high-risk sources; these included endocarditis, unknown source, endovascular infections other than catheter-related, central nervous system infections, and respiratory tract infections [21,22].”
BackgroundClinical characteristics associated with mortality of patients with anaerobic bacteremia
Umemura, T., Hamada, Y., Yamagishi, Y., Suematsu, H., & Mikamo, H. (2016) · Anaerobe · doi:10.1016/j.anaerobe.2016.02.007 · Cited by 39
Кirov, М. Y., Владимирович, К. В., Николаевич, П. Д., Щеголев, А. В., Babaev, M. A., Belotserkovskiy, B. Z., Bykov, A. O., Gritsan, A. I., Кулабухов, В. В., Kulikov, A. V., et al. (2023) · Annals of critical care · doi:10.21320/1818-474x-2023-4-7-42 · Cited by 44
Hsu, M.-S., Huang, Y., Hsu, H.-S., & Liao, C. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12608 · Cited by 37
Simor, A. E., Pelude, L., Golding, G. R., Fernandes, R., Bryce, E., Frenette, C. H., Gravel, D., Katz, K. C., McGeer, A., Mulvey, M. R., et al. (2016) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2015.323 · Cited by 32
“Similar to several previous investigations, we found that host factors, such as increasing age, and requirement for ICU admission (a marker of severity of disease) were associated with increased mortality.(6,9,10,17) Our results also indicate that certain “high risk” sources of BSI, such as pleuropulmonary infection,…”
BackgroundResultthe Korea INfectious Diseases (KIND) study group, Kang, C. K., Kim, Y. K., Jung, S., Park, W. B., Song, K., Park, K. U., Choe, P. G., Jang, H., Lee, S., et al. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3044-2 · Cited by 32
Hidalgo-Tenorio, C., Gálvez-Acebal, J., Martínez‐Marcos, F. J., Plata, A., Lima, J. D. L. T., López-Cortés, L. E., Noureddine, M., Reguera, J. M., García, D. V., García, M. V., et al. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-4895-1 · Cited by 33
Self-citationAhmad, O., Crawford, T. N., & Myint, T. (2019) · Infectious Diseases and Therapy · doi:10.1007/s40121-019-00277-2 · Cited by 31
Ayau, P., Bardossy, A. C., Rosenberg, G. F. S., Ortíz, R., Moreno, D., Hartman, P., Rizvi, K., Prentiss, T. C., Perri, M. B., Mahan, M., et al. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.05.010 · Cited by 32
“Therefore, early identification of MRSA BSI is important to optimize patient outcomes (Lee et al., 2013; Gasch et al., 2013a; Bassetti et al., 2011; Hernandez et al., 2015; Gasch et al., 2013b).”
BackgroundResultInfluentialEmergency medicine updates: Management of sepsis and septic shock
Long, B., & Gottlieb, M. A. (2025) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2025.01.054 · Cited by 34
Yin, S., Rao, G.-X., Wang, J., Luo, L., He, G., Wang, C., Ma, C., Luo, X., Hou, Z., & Xu, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143863 · Cited by 27
Kim, T., Chong, Y. P., Park, K., Bang, K. M., Park, S., Kim, S., Jeong, J., Lee, S., Choi, S., Woo, J. H., et al. (2017) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.351 · Cited by 25
“[6] reported that inappropriate antibiotic usage within 48 hours of MRSAB onset was independently associated with early mortality (aOR, 3.”
BackgroundResultInfluentialHung, Y.-P., Lee, C.-C., & Ko, W.-C. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.869822 · Cited by 29
Clinical characteristics, treatment and outcomes of MRSA bacteraemia in the elderly
Cuervo, G., Gasch, O., Shaw, E., Camoez, M., Domínguez, M. Á., Padilla, B., Pintado, V., Almirante, B., Lepe, J. A., López‐Medrano, F., et al. (2015) · Journal of Infection · doi:10.1016/j.jinf.2015.12.009 · Cited by 23
Self-citationYou, J. H. S., Choi, K., Wong, T.-Y., Ip, M., Ming, W., Wong, R. Y. K., Chan, S.-N., Tse, H.-T., Chau, C. T. S., & Lee, N. L. S. (2017) · Asia Pacific Journal of Public Health · doi:10.1177/1010539517717365 · Cited by 22
Chong, P. P., van Duin, D., Bangdiwala, A. S., Ivanova, A., Miller, W. C., Weber, D. J., Gilligan, P. H., & Shea, T. C. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.09.011 · Cited by 20
“It was previously validated as a tool to predict both shortand long-term mortality in patients with gram-negative BSI and methicillin-resistant S aureus BSI.(25,26) Our study and 1 other retrospective cohort study(27) suggest that the Pitt bacteremia score may be a reasonable alternative to the Charlson Comorbidity In…”
MethodWi, Y. M., Rhee, J.-Y., Kang, C., Chung, D. R., Song, J., & Peck, K. R. (2018) · Epidemiology and Infection · doi:10.1017/s0950268818001255 · Cited by 22
Staphylococcus aureus sepsis in rheumatoid arthritis
Sams, M., Olsen, M. A. A., Joshi, R., & Ranganathan, P. (2015) · Rheumatology International · doi:10.1007/s00296-015-3239-8 · Cited by 16
Antibiotic De-escalation in adults hospitalized for community-onset Sepsis
Gupta, A. B., Heath, M., Walzl, E., Ratz, D., Munroe, E., Vaughn, V. M., Horowitz, J. K., Czilok, T., Petty, L. A., Gandhi, T. N., et al. (2026) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2025.6919 · Cited by 14
Juan, R. S., Fernández‐Ruiz, M., Gasch, O., Camoez, M., López‐Medrano, F., Domínguez, M. Á., Almirante, B., Padilla, B., Pujol, M., Aguado, J. M., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx096 · Cited by 12
Self-citationMurai, T., Okazaki, K., Kinoshita, K., Uehara, Y., Zuo, H., Lu, Y., Ono, Y., Sasaki, T., Hiramatsu, K., & Horikoshi, Y. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.11.020 · Cited by 12
Mancini, S., Bodendoerfer, E., Kolesnik-Goldmann, N., Herren, S. C., Röthlin, K., Courvalin, P. M., & Böttger, E. C. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa336 · Cited by 13
da Costa, T. M., Cuba, G. T., Morgado, P. G. M., Nicolau, D. P., Nouér, S. A., dos Santos, K. R. N., & Kiffer, C. R. V. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-4782-9 · Cited by 6
Álvarez-Paredes, L., López, N., Rodrı́guez, J. C., Santibáñez, M., Belda, S., Galiana, A., López, P., Ruiz‐García, M., & Royo, G. (2013) · Chemotherapy · doi:10.1159/000362785 · Cited by 5
Management of MRSA/GISA, VISA Endocarditis
Jacqueline, C., Caillon, J., & Boutoille, D. (2013) · Current Infectious Disease Reports · doi:10.1007/s11908-013-0349-x · Cited by 4
“5 μg/mL in this study [47].”
[Current status of antibiotic therapy for Staphylococcus aureus sepsis in children].
Li, Y., Li, Q., Zhang, G., Tian, X., Chen, D., & Luo, Z. (2019) · PubMed · doi:10.7499/j.issn.1008-8830.2019.04.016 · Cited by 3
Proquot, M., Jamal, L. N., Plouzeau-Jayle, C., Michaud, A. L., Broutin, L., Burucoa, C., Cremniter, J., & Pichon, M. (2021) · Microorganisms · doi:10.3390/microorganisms9091884 · Cited by 4
An Electronic Algorithm to Identify Vancomycin-Associated Acute Kidney Injury
Cherian, J. P., Jones, G. F., Bachina, P., Helsel, T., Virk, Z., Lee, J. H., Fiawoo, S., Salinas, A. B., Dzintars, K., O’Shaughnessy, E. M., et al. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad264 · Cited by 3
Pea, F., Petrosillo, N., & Garau, J. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1056159
“Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most challenging bacterial pathogens responsible for severe infections among hospitalized patients, like bacteremia, and pneumonia, often with high mortality rates [1,2].”
BackgroundCallejo-Torre, F. (2015) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/14330
Clinical Insights: Staphylococcus aureus Antibiotic Resistance
Dancer, S. J. (2014) · doi:10.2217/9781780843698
López, A. M., Peraza, G. T. T., Novo, L. D., & Vivanco, M. M. V.-D. (2016) · Revista panorama/Panorama. Cuba y salud
Role of rapid diagnostics in selecting optimal therapy forStaphylococcus aureusinfections
Proctor, R. A., & Smith, D. (2014) · doi:10.2217/ebo.13.688
Li, Z., Zhuang, H., Wang, G., Wang, H., & Dong, Y. (2020) · doi:10.21203/rs.3.rs-37537/v1
MCCANN, T., Fatuyi, M. A., Patel, N., Sharath, D. B., & Patel, A. (2022) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2022/8965888
“(ese previous studies, however, focus primarily on initial infection source, locations of acquisition, and appropriate treatments [10, 24, 25].”
BackgroundOrtiz, S. L. D. (2020) · Repositorio Institucional (Pontificia Universidad Javeriana) · doi:10.11144/javeriana.10554.9889
Li, Z., Zhuang, H., Wang, G., Wang, H., & Dong, Y. (2021) · Figshare · doi:10.6084/m9.figshare.13579200
Li, Z., Zhuang, H., Wang, G., Wang, H., & Dong, Y. (2021) · Figshare · doi:10.6084/m9.figshare.13579203
Li, Z., Zhuang, H., Wang, G., Wang, H., & Dong, Y. (2021) · Figshare · doi:10.6084/m9.figshare.13579206
Khazaeinejad, A., Kargar, M., Foroudi, M. R., & Hamidizadeh, L. (2026) · Jundishapur Journal of Microbiology · doi:10.5812/jjm-165954
Metadata
- Authors
- Gasch, O., Camoez, M., Dominguez, M. A., Padilla, B., Pintado, V., Almirante, B., Lepe, J. A., Lagarde, M., Ruiz de Gopegui, E., Martinez, J. A., Montejo, M., Torre-Cisneros, J., Arnaiz, A., Goenaga, M. A., Benito, N., Rodriguez-Bano, J., Pujol, M., & Groups, O. B. O. T. R. S.
- Affiliations
- Bellvitge University Hospital (ES)
- Hospital General Universitario Gregorio Marañón (ES)
- Hospital Universitario Ramón y Cajal (ES)
- Vall d'Hebron Hospital Universitari (ES)
- Hospital Universitario Virgen del Rocío (ES)
- Hospital Universitario 12 De Octubre (ES)
- Hospital de Cruces (ES)
- Hospital de Sant Pau (ES)
- Corresponding author
- Gasch, O.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-02-12
- Volume
- 68
- Issue
- 6
- Pages
- 1423-1430
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2157744708
- Cited by
- 52
- References
- 47
- Citations by year
- 2026: 1 · 2025: 2 · 2023: 2 · 2022: 2 · 2021: 7 · 2020: 5 · 2019: 2 · 2018: 2 · 2017: 8 · 2016: 4 · 2015: 8 · 2014: 4 · 2013: 5
- FWCI
- 5.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Antimicrobial Chemotherapy (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Instituto de Salud Carlos III (RD06/0008, FIS 08/0335)
- European Regional Development Fund
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- methicillin-resistant Staphylococcus aureus, bacteremia, early mortality, late mortality, risk factors, Pitt score, endocarditis, lower respiratory tract infection
- MeSH terms
- Age Factors, Aged, Female, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Predictive Value of Tests, Risk Factors, Sex Factors, Staphylococcal Infections, Cohort Studies, Logistic Models, Bacteremia, Treatment Outcome, Drug Resistance, Bacterial, Methicillin-Resistant Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.